cas: 1086062-66-9 — see every product listed under this CAS number, including other names
Omipalisib, 99.94% (CAS 1086062-66-9) is a chemical reagent available from Chemat. Available pack sizes: 100 mg, 5 mg, 10mM/1mL, 10 mg, 50 mg, 25 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-10297-100 mg |
| cas | 1086062-66-9 |
| size | 100 mg |
| availability | In stock |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 100 mg | 2711.35 Pln | |
| MedChemExpress | 5 mg | 463.66 Pln | |
| MedChemExpress | 10mM/1mL | 500.81 Pln | |
| MedChemExpress | 10 mg | 700.50 Pln | |
| MedChemExpress | 50 mg | 1870.79 Pln | |
| MedChemExpress | 25 mg | 1215.98 Pln |
| delivery time | 2-3 weeks |
|---|---|
| purity | 99.94% |
Omipalisib is a member of the class of quinolines that is quinoline which is substituted by pyridazin-4-yl and 5-[(2,4-difluorobenzene-1-sulfonyl)amino]-6-methoxypyridin-3-yl groups at positions 4 and 6, respectively. It is a highly potent inhibitor of PI3K and mTOR developed by GlaxoSmithKline and was previously in human phase 1 clinical trials for the treatment of idiopathic pulmonary fibrosis and solid tumors. It has a role as a radiosensitizing agent, an autophagy inducer, an anticoronaviral agent, an antifibrotic agent, an antineoplastic agent, an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and a mTOR inhibitor. It is a member of pyridines, a member of quinolines, a sulfonamide, an aromatic ether, a member of pyridazines and a difluorobenzene.
Source: ChEBI
| Molecular formula | C25H17F2N5O3S |
|---|---|
| Molecular weight | 505.5 g/mol |
| IUPAC name | 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)-3-pyridinyl]benzenesulfonamide |
| InChIKey | CGBJSGAELGCMKE-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F |
Computed by PubChem (NCBI)